Holen Sie sich die Stockscreener-App
364.98
0.01%
-0.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$365.01
Offen:
$364.74
24-Stunden-Volumen:
472.11K
Relative Volume:
0.74
Marktkapitalisierung:
$25.69B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
48.79
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
-1.47%
1M Leistung:
+6.52%
6M Leistung:
+43.24%
1J Leistung:
+33.61%
1-Tages-Spanne:
$363.26
$368.85
1-Wochen-Bereich:
$363.12
$378.47
52-Wochen-Spanne:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
364.98 | 26.07B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
391.95 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list - cnbc.com
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services stock reports 13.80 percent revenue growth - AD HOC NEWS
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research
West Pharmaceutical Services stock attracts analyst coverage - AD HOC NEWS
West Pharmaceutical stock enters earnings watch with USD 382.00 target - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
What Comes Next for West Pharmaceutical Services (NYSE:WST)? - Kalkine Media
Top West Pharmaceutical Services (WST) Competitors 2026 - MarketBeat
West Pharmaceutical Services stock gains after target rises - AD HOC NEWS
West Pharmaceutical stock rises 1.30 percent ahead of the open - AD HOC NEWS
West Pharmaceutical stock rises 2.71 percent after analyst upgrade - AD HOC NEWS
West Pharmaceutical stock gains 2.57 percent before the bell - AD HOC NEWS
West Pharmaceutical stock gains as Morgan Stanley turns bullish - AD HOC NEWS
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says - marketscreener.com
West Pharmaceutical Services stock holds near its yearly range - AD HOC NEWS
Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 - Yahoo Finance
West Pharmaceutical stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with 11.89% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical stock heads into the open after a 1.3% drop - AD HOC NEWS
West Pharmaceutical Services stock holds near fair value as valuation debate intensifies - AD HOC NEWS
What Is Drawing Attention To West Pharmaceutical Services (WST)? - Yahoo Finance
West Pharmaceutical Services stock holds a Moderate Buy rating - AD HOC NEWS
West Pharmaceutical stock holds Moderate Buy rating as Annex 1 work shapes outlook - ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Yahoo Finance
West Pharma to cut 98 jobs as SmartDose production winds down in Arizona - Plastics News
West Pharmaceutical stock slips after recent Fed-driven drop but Q2 2026 results stay strong - AD HOC NEWS
West Pharmaceutical stock heads into the open after a sharp drop - AD HOC NEWS
West Pharmaceutical stock gains after raised 2026 guidance and strong Q2 figures - AD HOC NEWS
West Pharmaceutical stock heads into the open after a 2.76% gain - AD HOC NEWS
Is West Pharmaceutical Services Stock Outperforming the Nasdaq? - Yahoo Finance
West Pharmaceutical (NYSE: WST) HR leader exercises options, then sells 7,524 shares - Stock Titan
West Pharmaceutical Services Inc (WST): GF Score of 95 Signals S - GuruFocus
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $365 - Moomoo
West Pharmaceutical stock heads into the open after a 1.8% gain - AD HOC NEWS
Earnings Call Transcripts - Investing.com
West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside - DirectorsTalk Interviews
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - Investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
WEST PHARMACEUTICAL SERVICES, INC. : UBS RAISES TARGET PRICE TO $415 FROM $340 - webull.com
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - Investing.com
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):